10/4/2022  12:00:00 AM Chg. +143.00 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
5,225.00MXN +2.81% 11
Turnover: -
-Bid Size: - -Ask Size: - 329.58 bill.MXN - -

Business description

Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support. The products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart.
 

Management board & Supervisory board

CEO
Michael R. Minogue
Management board
Todd A. Trapp, Andrew J. Greenfield, Chuck A. Simonton, Dr. Thorsten Siess, Karen Mahoney, Laxmi Peri, Marc Began, Matt Plano
Supervisory board
Michael R. Minogue, Chris Van Gorder, Dorothy E. Puhy, Dr. Myron L. Rolle, Dr. Paula A. Johnson, Eric Rose, Jeannine Rivet, Martin P. Sutter, Paul G. Thomas, W. Gerald Austen
 

Company data

Name: Abiomed Inc.
Address: 22 Cherry Hill Drive,Danvers, Massachusetts 01923, USA
Phone: +1-978-646-1400
Fax: +1-978-777-8411
E-mail: -
Internet: www.abiomed.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 3/31
Free Float: 73.60%
IPO date: -

Investor relations

Name: Todd Trapp
IR phone: +1-978-646-1680
IR Fax: -
IR e-mail: ir@abiomed.com

Main Shareholders

Freefloat
 
73.60%
The Vanguard Group, Inc.
 
10.60%
Blackrock, Inc.
 
9.10%
Baillie Gifford & Co
 
6.70%
Others
 
0.00%